Skip to main content
Erschienen in: Abdominal Radiology 6/2015

01.08.2015

MR–PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations

verfasst von: Miguel Ramalho, Mamdoh AlObaidy, Lauren M. Burke, Brian M. Dale, David A. Gerber, Terence Z. Wong, Richard C. Semelka

Erschienen in: Abdominal Radiology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to evaluate the feasibility and protocol optimization of whole-body hybrid MR–PET system performed 1-month after post-locoregional thermoablative procedures for hepatocellular carcinomas (HCCs).

Materials and methods

Eight patients (6 men and 2 women; mean age, 56.6 ± 5.5 years) with 9 ablated HCCs constituted our study population. Three readers interpreted the studies to determine the presence or absence of residual malignancy. Two readers independently assessed the fused MR–PET images to compare registration accuracy of two types of T2-weighted (triggered T2 half-Fourier acquisition single-shot turbo spin-echo and turbo spin-echo) and T1-weighted [Cartesian and radial 3D gradient echo (GRE)]. Image quality evaluation of both 3D-GRE T1-weighted sequences was evaluated. Kappa statistics were used to measure inter-observer agreement. Non-parametric Kruskal–Wallis and Wilcoxon signed-rank tests were used for qualitative data analysis.

Results

Definite residual tumor was observed in 3/9 ablations; two were PET positive. All residual tumors were isovascular on MRI. Radial 3D-GRE demonstrated significantly superior MR–PET subjective co-registration in comparison with the remaining sequences and showed a non-significant trend toward higher image quality scores than Cartesian GRE.

Conclusion

Whole-body hybrid MR–PET is feasible as a part of 1-month follow-up post-locoregional thermoablative treatment for HCC. Radial 3D-GRE offers improved co-registration with PET data, with overall good image quality.
Literatur
1.
Zurück zum Zitat N’Kontchou G, Mahamoudi A, Aout M, et al. (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50:1475–1483. doi:10.1002/hep.23181 PubMedCrossRef N’Kontchou G, Mahamoudi A, Aout M, et al. (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50:1475–1483. doi:10.​1002/​hep.​23181 PubMedCrossRef
2.
Zurück zum Zitat Lencioni R, Cioni D, Crocetti L, et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967. doi:10.1148/radiol.2343040350 PubMedCrossRef Lencioni R, Cioni D, Crocetti L, et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967. doi:10.​1148/​radiol.​2343040350 PubMedCrossRef
3.
Zurück zum Zitat Peng Z-W, Lin X-J, Zhang Y-J, et al. (2012) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262:1022–1033. doi:10.1148/radiol.11110817 PubMedCrossRef Peng Z-W, Lin X-J, Zhang Y-J, et al. (2012) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262:1022–1033. doi:10.​1148/​radiol.​11110817 PubMedCrossRef
4.
5.
8.
Zurück zum Zitat Yoon J-H, Lee E-J, Cha S-S, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21:348–356. doi:10.1016/j.jvir.2009.11.014 PubMedCrossRef Yoon J-H, Lee E-J, Cha S-S, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21:348–356. doi:10.​1016/​j.​jvir.​2009.​11.​014 PubMedCrossRef
10.
Zurück zum Zitat Kierans AS, Elazzazi M, Braga L, et al. (2010) Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. Am J Roentgenol 194:523–529. doi:10.2214/AJR.09.2621 CrossRef Kierans AS, Elazzazi M, Braga L, et al. (2010) Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. Am J Roentgenol 194:523–529. doi:10.​2214/​AJR.​09.​2621 CrossRef
11.
Zurück zum Zitat Paudyal B, Oriuchi N, Paudyal P, et al. (2007) Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep 18:1469–1473PubMed Paudyal B, Oriuchi N, Paudyal P, et al. (2007) Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep 18:1469–1473PubMed
13.
Zurück zum Zitat Imamura H, Matsuyama Y, Tanaka E, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207PubMedCrossRef Imamura H, Matsuyama Y, Tanaka E, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207PubMedCrossRef
15.
Zurück zum Zitat Cheung TT, Chan SC, Ho CL, et al. (2011) Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl 17:1218–1225. doi:10.1002/lt.22362 PubMedCrossRef Cheung TT, Chan SC, Ho CL, et al. (2011) Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl 17:1218–1225. doi:10.​1002/​lt.​22362 PubMedCrossRef
17.
19.
Zurück zum Zitat Curley SA, Izzo F, Delrio P, et al. (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230:1–8PubMedCentralPubMedCrossRef Curley SA, Izzo F, Delrio P, et al. (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230:1–8PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Ozkavukcu E, Haliloglu N, Erden A (2009) Post-treatment MRI findings of hepatocellular carcinoma. Diagn Interv Radiol 15:111–120PubMed Ozkavukcu E, Haliloglu N, Erden A (2009) Post-treatment MRI findings of hepatocellular carcinoma. Diagn Interv Radiol 15:111–120PubMed
21.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
23.
Zurück zum Zitat Pitton MB, Kloeckner R, Herber S, et al. (2009) MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. World J Gastroenterol 15:6044–6051PubMedCentralPubMedCrossRef Pitton MB, Kloeckner R, Herber S, et al. (2009) MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. World J Gastroenterol 15:6044–6051PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Kloeckner R, Otto G, Biesterfeld S, et al. (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:532–540. doi:10.1007/s00270-009-9728-y PubMedCrossRef Kloeckner R, Otto G, Biesterfeld S, et al. (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:532–540. doi:10.​1007/​s00270-009-9728-y PubMedCrossRef
25.
Zurück zum Zitat Golfieri R, Marini E, Bazzocchi A, et al. (2009) Small (<or = 3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med 114:1239–1266. doi:10.1007/s11547-009-0439-x PubMedCrossRef Golfieri R, Marini E, Bazzocchi A, et al. (2009) Small (<or = 3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med 114:1239–1266. doi:10.​1007/​s11547-009-0439-x PubMedCrossRef
26.
Zurück zum Zitat Qu J-R, Liu C-C, Zhang H-K, et al. (2012) Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 34:480–485. doi:10.3881/j.issn.1000-503X.2012.05.008 PubMed Qu J-R, Liu C-C, Zhang H-K, et al. (2012) Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 34:480–485. doi:10.​3881/​j.​issn.​1000-503X.​2012.​05.​008 PubMed
27.
28.
Zurück zum Zitat Kim KA, Kim M-J, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634. doi:10.1002/jmri.22876 PubMedCrossRef Kim KA, Kim M-J, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634. doi:10.​1002/​jmri.​22876 PubMedCrossRef
30.
Zurück zum Zitat Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? Am J Roentgenol 196:1083–1089. doi:10.2214/AJR.10.4720 CrossRef Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? Am J Roentgenol 196:1083–1089. doi:10.​2214/​AJR.​10.​4720 CrossRef
31.
Zurück zum Zitat Higashi T, Hatano E, Ikai I, et al. (2010) FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 37:468–482. doi:10.1007/s00259-009-1284-9 PubMedCrossRef Higashi T, Hatano E, Ikai I, et al. (2010) FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 37:468–482. doi:10.​1007/​s00259-009-1284-9 PubMedCrossRef
33.
Zurück zum Zitat Rakheja R, DeMello L, Chandarana H, et al. (2013) Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions. Am J Roentgenol 201:1120–1123. doi:10.2214/AJR.13.11305 CrossRef Rakheja R, DeMello L, Chandarana H, et al. (2013) Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions. Am J Roentgenol 201:1120–1123. doi:10.​2214/​AJR.​13.​11305 CrossRef
34.
Zurück zum Zitat Reiner CS, Neville AM, Nazeer HK, et al. (2013) Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties. Eur Radiol 23:3087–3093. doi:10.1007/s00330-013-2910-2 PubMedCrossRef Reiner CS, Neville AM, Nazeer HK, et al. (2013) Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties. Eur Radiol 23:3087–3093. doi:10.​1007/​s00330-013-2910-2 PubMedCrossRef
35.
Zurück zum Zitat Azevedo RM, de Campos ROP, Ramalho M, et al. (2011) Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI: preliminary observations. Am J Roentgenol 197:650–657. doi:10.2214/AJR.10.5881 CrossRef Azevedo RM, de Campos ROP, Ramalho M, et al. (2011) Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI: preliminary observations. Am J Roentgenol 197:650–657. doi:10.​2214/​AJR.​10.​5881 CrossRef
36.
Zurück zum Zitat Chandarana H, Block TK, Rosenkrantz AB, et al. (2011) Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol 46:648–653. doi:10.1097/RLI.0b013e31821eea45 PubMedCrossRef Chandarana H, Block TK, Rosenkrantz AB, et al. (2011) Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol 46:648–653. doi:10.​1097/​RLI.​0b013e31821eea45​ PubMedCrossRef
Metadaten
Titel
MR–PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations
verfasst von
Miguel Ramalho
Mamdoh AlObaidy
Lauren M. Burke
Brian M. Dale
David A. Gerber
Terence Z. Wong
Richard C. Semelka
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0436-6

Weitere Artikel der Ausgabe 6/2015

Abdominal Radiology 6/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.